The IDEXX Laboratories, Inc. - line shows up 30 times in the congressional disclosure record between 2015 and 2026, filed by 7 members: 17 purchases against 13 sales. On balance the chamber has been net buyers, and the purchases sit up 17.9% against the latest close.
*Purchases only, weighted by the midpoint of each disclosed dollar band and marked to the latest close. Filings report a range, never a share count, so this follows the stock rather than anyone's position size.
Reported a IDXX purchase in filings from the last 90 days, newest first. 1 member.
Members ranked by how their reported IDXX purchases have moved since, over roughly the last three years, weighted by disclosed band midpoint and marked to the latest close.
| Date | Member | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2026-09-04 | Rohit Khanna | SELL | $1K–$15K | $535.38 | $570.21 2026-10-26 | -6.5% exit |
| 2026-08-03 | Rohit Khanna | BUY | $1K–$15K | $567.84 | $535.38 2026-09-04 | -5.7% |
| 2026-03-30 | Rohit Khanna | BUY | $1K–$15K | $557.09 | $535.38 2026-09-04 | -3.9% |
| 2026-01-13 | April McClain Delaney | SELL | $1K–$15K | $714.04 | $535.38 2026-09-04 | +25.0% exit |
| 2025-12-02 | April McClain Delaney | SELL | $1K–$15K | $732.73 | $535.38 2026-09-04 | +26.9% exit |
| 2025-10-29 | April McClain Delaney | SELL | $1K–$15K | $627.66 | $535.38 2026-09-04 | +14.7% exit |
| 2025-10-16 | April McClain Delaney | SELL | $1K–$15K | $637.34 | $535.38 2026-09-04 | +16.0% exit |
| 2025-09-04 | Byron Donalds | BUY | $1K–$15K | $640.44 | $535.38 2026-09-04 | -16.4% |
| 2025-08-07 | April McClain Delaney | SELL | $1K–$15K | $650.06 | $535.38 2026-09-04 | +17.6% exit |
| 2025-08-01 | April McClain Delaney | SELL | $1K–$15K | $535.54 | $535.38 2026-09-04 | +0.0% exit |
| 2025-07-09 | April McClain Delaney | SELL | $1K–$15K | $540.64 | $535.38 2026-09-04 | +1.0% exit |
| 2025-04-09 | April McClain Delaney | BUY | $1K–$15K | $397.10 | $535.38 2026-09-04 | +34.8% |
| 2025-04-07 | April McClain Delaney | BUY | $1K–$15K | $378.99 | $535.38 2026-09-04 | +41.3% |
| 2025-04-04 | April McClain Delaney | BUY | $1K–$15K | $393.73 | $535.38 2026-09-04 | +36.0% |
| 2025-04-01 | April McClain Delaney | BUY | $1K–$15K | $418.57 | $535.38 2026-09-04 | +27.9% |
| 2025-03-14 | April McClain Delaney | BUY | $1K–$15K | $415.30 | $535.38 2026-09-04 | +28.9% |
| 2024-01-22 | Thomas H Tuberville | SELL | $1K–$15K | $531.43 | $535.38 2026-09-04 | -0.7% exit |
| 2023-04-03 | Thomas H Tuberville | BUY | $1K–$15K | $489.27 | $535.38 2026-09-04 | +9.4% |
| 2023-04-03 | Thomas H Tuberville | BUY | $1K–$15K | $489.27 | $535.38 2026-09-04 | +9.4% |
| 2022-10-05 | Thomas H Tuberville | SELL | $1K–$15K | $350.12 | $535.38 2026-09-04 | -52.9% exit |
| 2022-08-01 | Rohit Khanna | BUY | $1K–$15K | $398.13 | $535.38 2026-09-04 | +34.5% |
| 2022-06-16 | Rohit Khanna | BUY | $1K–$15K | $327.37 | $535.38 2026-09-04 | +63.5% |
| 2021-03-29 | Thomas H Tuberville | BUY | $1K–$15K | $479.18 | $535.38 2026-09-04 | +11.7% |
| 2020-08-11 | Gilbert Cisneros | SELL | $1K–$15K | $374.03 | $535.38 2026-09-04 | -43.1% exit |
| 2017-11-30 | Rohit Khanna | BUY | $1K–$15K | $156.41 | $535.38 2026-09-04 | +242.3% |
| 2017-11-28 | Rohit Khanna | SELL | $1K–$15K | $155.02 | $535.38 2026-09-04 | -245.4% exit |
| 2017-04-05 | John K. Delaney | BUY | $1K–$15K | $154.72 | $535.38 2026-09-04 | +246.0% |
| 2017-03-09 | John K. Delaney | BUY | $1K–$15K | $149.41 | $535.38 2026-09-04 | +258.3% |
| 2017-03-07 | John K. Delaney | BUY | $1K–$15K | $147.03 | $535.38 2026-09-04 | +264.1% |
| 2015-06-02 | Lamar Smith | SELL | $1K–$15K | $67.03 | $570.21 2026-10-26 | -750.6% exit |
Buys are marked to the latest close and treated as open. A sell tagged rt closes an earlier disclosed buy in the same name. exit shows how the stock moved after the member sold.
7 members of the U.S. House and Senate have disclosed IDEXX Laboratories, Inc. - transactions under the STOCK Act — 17 purchases and 13 sales. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.
1 member disclosed a IDXX purchase in the last 90 days — most recently Rohit Khanna on 2026-08-03. See the "Lawmakers who bought IDXX recently" section above for the dated list.
Notional-weighted, lawmakers' disclosed IDXX buys are up 17.9% versus the latest close of $570.21. Each trade's own return — and realized round-trips on matched sells — is in the Return column.
Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded IDXX and how it performed.